Class information for:
Level 1: MOTOR FLUCTUATIONS//LEVODOPA//DYSKINESIA

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
339 3551 42.8 72%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
165 21626 PARKINSONS DISEASE//DEEP BRAIN STIMULATION//MOVEMENT DISORDERS

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 MOTOR FLUCTUATIONS Author keyword 209 69% 5% 181
2 LEVODOPA Author keyword 206 33% 15% 520
3 DYSKINESIA Author keyword 201 41% 11% 376
4 DYSKINESIAS Author keyword 118 52% 4% 159
5 WEARING OFF Author keyword 100 76% 2% 70
6 MOTOR COMPLICATIONS Author keyword 86 67% 2% 78
7 CONTINUOUS DOPAMINERGIC STIMULATION Author keyword 69 83% 1% 39
8 L DOPA Author keyword 47 17% 7% 248
9 ROTIGOTINE Author keyword 45 54% 2% 59
10 L DOPA INDUCED DYSKINESIA Author keyword 44 63% 1% 45

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 MOTOR FLUCTUATIONS 209 69% 5% 181 Search MOTOR+FLUCTUATIONS Search MOTOR+FLUCTUATIONS
2 LEVODOPA 206 33% 15% 520 Search LEVODOPA Search LEVODOPA
3 DYSKINESIA 201 41% 11% 376 Search DYSKINESIA Search DYSKINESIA
4 DYSKINESIAS 118 52% 4% 159 Search DYSKINESIAS Search DYSKINESIAS
5 WEARING OFF 100 76% 2% 70 Search WEARING+OFF Search WEARING+OFF
6 MOTOR COMPLICATIONS 86 67% 2% 78 Search MOTOR+COMPLICATIONS Search MOTOR+COMPLICATIONS
7 CONTINUOUS DOPAMINERGIC STIMULATION 69 83% 1% 39 Search CONTINUOUS+DOPAMINERGIC+STIMULATION Search CONTINUOUS+DOPAMINERGIC+STIMULATION
8 L DOPA 47 17% 7% 248 Search L+DOPA Search L+DOPA
9 ROTIGOTINE 45 54% 2% 59 Search ROTIGOTINE Search ROTIGOTINE
10 L DOPA INDUCED DYSKINESIA 44 63% 1% 45 Search L+DOPA+INDUCED+DYSKINESIA Search L+DOPA+INDUCED+DYSKINESIA

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 MOTOR FLUCTUATIONS 613 64% 17% 604
2 LEVODOPA INDUCED DYSKINESIAS 203 51% 8% 285
3 SUBCUTANEOUS APOMORPHINE 189 75% 4% 136
4 LEVODOPA INDUCED DYSKINESIA 179 54% 7% 234
5 CONTINUOUS DOPAMINERGIC STIMULATION 154 91% 2% 63
6 CENTRAL PATHOPHYSIOLOGICAL MECHANISMS 152 81% 3% 91
7 LEVODOPA 141 22% 16% 582
8 MOTOR COMPLICATIONS 113 64% 3% 109
9 DOPA INDUCED DYSKINESIA 109 47% 5% 169
10 ON OFF FLUCTUATIONS 94 89% 1% 42

Journals


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 CLINICAL NEUROPHARMACOLOGY 27 11% 7% 244

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Molecular mechanisms of L-DOPA-induced dyskinesia 2008 191 183 60%
Therapeutic strategies to prevent and manage dyskinesias in Parkinson's disease 2015 3 91 75%
Novel Formulations and Modes of Delivery of Levodopa 2015 2 37 95%
Levodopa-induced dyskinesias in patients with Parkinson's disease: filling the bench-to-bedside gap 2010 91 91 73%
Use of metabotropic glutamate 5-receptor antagonists for treatment of levodopa-induced dyskinesias 2014 11 66 86%
The Pharmacology of L-DOPA-Induced Dyskinesia in Parkinson's Disease 2013 45 560 53%
Levodopa-induced dyskinesias 2007 142 56 75%
Pharmacological Treatment of Parkinson Disease A Review 2014 46 117 22%
Levodopa Therapy for Parkinson's Disease: Pharmacokinetics and Pharmacodynamics 2015 2 62 69%
Duodenal levodopa infusion monotherapy vs oral polypharmacy in advanced Parkinson disease 2005 197 23 65%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 BASAL GANGLIA PATHOPHYSIOL UNIT 28 55% 1.0% 35
2 MANCHESTER MOVEMENT DISORDER 11 56% 0.4% 14
3 HLTH BIOMED SCI 7 31% 0.5% 18
4 EXPT THER EUT BRANCH 6 16% 0.9% 32
5 SERV NEUROL NEUROL EXPT 6 100% 0.1% 4
6 PARKINSONS DIS MOVEMENT DISORDERS 5 12% 1.0% 35
7 MOVEMENT DISORDER CLIN 5 23% 0.5% 17
8 CLIN INVEST CLIN PHARMACOL 4 75% 0.1% 3
9 MOL ENDOCRINOL GENOM 4 33% 0.3% 10
10 HBEREICH NEUROL 3 29% 0.3% 10

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000192811 L DOPA PRODRUGS//6 HYDROXYDOPAMINE 6 OHDA LESIONED RAT//PROXIMAGEN NEUROSCI PLC
2 0.0000140966 TERGURIDE//ERGOLINE//DOPAMINE D 2 AGONIST
3 0.0000117756 RASAGILINE//SELEGILINE//DEPRENYL
4 0.0000105742 VALVULOPATHY//DRUG INDUCED VALVULAR DISEASE//ERGOT DERIVED DOPAMINE AGONISTS
5 0.0000103905 PDQ 39//NON MOTOR SYMPTOMS//PARKINSONS DISEASE QUESTIONNAIRE
6 0.0000098813 CHRONIC BILATERAL SUBTHALAMIC STIMULATION//ACOUSTIC BLINK REFLEX//FAMILY INTERNAL MED
7 0.0000091639 CATECHOL O METHYLTRANSFERASE//COMT//TOLCAPONE
8 0.0000083372 DOPAMINE DYSREGULATION SYNDROME//PUNDING//IMPULSE CONTROL DISORDERS
9 0.0000069520 MOL CELLULAR TOXICOL HUMAN PLICAT//OULU CITY HOSP//DOOR TO DOOR SURVEYS
10 0.0000066218 NEUROMELANIN//AMINOCHROME//5 S CYSTEINYLDOPAMINE